Systematic  	Systematic  	 JJ	B-NP
review  	review  	 NN	I-NP
and  	and  	 CC	O
mixed  	mixed  	 JJ	O
treatment  	treatment  	 NN	B-NP
comparison  	comparison  	 NN	I-NP
of  	of  	 IN	I-NP
randomized  	randomized  	 JJ	I-NP
evidence  	evidence  	 NN	I-NP
for  	for  	 IN	O
empirical 	empirical 	 NN	O
,  	,  	 ,	O
pre-emptive  	pre-emptive  	 JJ	O
and  	and  	 CC	O
directed  	directed  	 JJ	O
treatment  	treatment  	 NN	B-NP
strategies  	strategies  	 NNS	I-NP
for  	for  	 IN	I-NP
invasive  	invasive  	 FW	I-NP
mould  	mould  	 FW	I-NP
disease  	disease  	 FW	I-NP
Randomized  	Randomized  	 FW	O
controlled  	controlled  	 FW	B-NP
trials  	trials  	 FW	I-NP
( 	( 	 -LRB-	O
RCTs 	RCTs 	 NNP	B-NP
)  	)  	 -RRB-	O
provide  	provide  	 VB	O
the  	the  	 DT	O
most  	most  	 RBS	O
reliable  	reliable  	 JJ	O
estimates  	estimates  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
treatments 	treatments 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
not  	not  	 RB	O
all  	all  	 DT	O
treatments  	treatments  	 NNS	O
are  	are  	 VBP	O
compared  	compared  	 VBN	O
in  	in  	 IN	O
available  	available  	 JJ	O
RCTs 	RCTs 	 NN	B-NP
,  	,  	 ,	O
making  	making  	 VBG	B-NP
comparison  	comparison  	 NN	I-NP
of  	of  	 IN	O
treatments  	treatments  	 JJ	O
problematic 	problematic 	 NN	O
.  	.  	 .	O
Mixed  	Mixed  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
comparisons  	comparisons  	 NNS	I-NP
( 	( 	 -LRB-	O
MTCs 	MTCs 	 NNP	B-NP
)  	)  	 -RRB-	O
can  	can  	 MD	O
provide  	provide  	 VB	O
estimates  	estimates  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
comparative  	comparative  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	O
treatments  	treatments  	 NNS	O
across  	across  	 IN	O
a  	a  	 DT	O
range  	range  	 NN	O
of  	of  	 IN	O
available  	available  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
options 	options 	 NNS	I-NP
.  	.  	 .	O
MTCs  	MTCs  	 JJ	B-NP
use  	use  	 NN	I-NP
networks  	networks  	 NNS	I-NP
of  	of  	 IN	O
available  	available  	 JJ	O
direct  	direct  	 JJ	O
comparisons  	comparisons  	 NNS	O
to  	to  	 TO	O
estimate  	estimate  	 VB	O
differences  	differences  	 NNS	O
in  	in  	 IN	O
treatments  	treatments  	 NNS	O
that  	that  	 WDT	O
have  	have  	 VBP	O
not  	not  	 RB	O
been  	been  	 VBN	O
estimated  	estimated  	 VBN	O
in  	in  	 IN	O
trials  	trials  	 NNS	O
via  	via  	 IN	O
a  	a  	 DT	O
common  	common  	 JJ	O
comparator 	comparator 	 NN	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
conducted  	conducted  	 VBD	O
a  	a  	 DT	O
systematic  	systematic  	 JJ	B-NP
review  	review  	 NN	I-NP
and  	and  	 CC	O
MTCs  	MTCs  	 JJ	O
of  	of  	 IN	O
comparative  	comparative  	 JJ	B-NP
RCTs  	RCTs  	 NN	I-NP
in  	in  	 IN	O
haematological  	haematological  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
of  	of  	 IN	I-NP
anti-mould  	anti-mould  	 JJ	I-NP
active  	active  	 JJ	O
agents  	agents  	 NNS	O
used  	used  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
empirical  	empirical  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
of  	of  	 IN	O
febrile  	febrile  	 JJ	O
neutropenia  	neutropenia  	 NNS	B-NP
( 	( 	 -LRB-	O
Analysis  	Analysis  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
pre-emptive  	pre-emptive  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
( 	( 	 -LRB-	O
Analysis  	Analysis  	 NNP	O
2 	2 	 CD	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
invasive  	invasive  	 JJ	B-NP
mould  	mould  	 JJ	I-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
we  	we  	 PRP	O
summarized  	summarized  	 VBD	O
the  	the  	 DT	O
evidence  	evidence  	 NN	O
available  	available  	 JJ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
directed  	directed  	 JJ	O
treatment  	treatment  	 NN	B-NP
strategies  	strategies  	 NNS	I-NP
( 	( 	 -LRB-	O
Analysis  	Analysis  	 NNP	O
3 	3 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
empirical  	empirical  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
,  	,  	 ,	O
caspofungin  	caspofungin  	 VBD	O
proved  	proved  	 VBN	O
superior  	superior  	 JJ	O
to  	to  	 TO	O
amphotericin  	amphotericin  	 VB	O
B 	B 	 NNP	O
,  	,  	 ,	O
liposomal  	liposomal  	 FW	B-NP
amphotericin  	amphotericin  	 FW	I-NP
B 	B 	 NNP	I-NP
,  	,  	 ,	O
amphotericin  	amphotericin  	 JJ	B-NP
B  	B  	 NN	I-NP
lipid  	lipid  	 NN	I-NP
complex  	complex  	 NN	I-NP
and  	and  	 CC	O
voriconazole  	voriconazole  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
outcome  	outcome  	 NN	O
of  	of  	 IN	O
survival 	survival 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
no  	no  	 DT	O
agents  	agents  	 NNS	O
showed  	showed  	 VBD	O
superiority  	superiority  	 VBN	O
for  	for  	 IN	O
treatment  	treatment  	 NN	B-NP
response 	response 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
evidence  	evidence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
difference  	difference  	 NN	O
between  	between  	 IN	O
pre-emptive  	pre-emptive  	 JJ	O
and  	and  	 CC	O
empirical  	empirical  	 JJ	B-NP
strategies  	strategies  	 NNS	I-NP
on  	on  	 IN	O
mortality  	mortality  	 NN	B-NP
outcomes 	outcomes 	 NNS	I-NP
.  	.  	 .	O
For  	For  	 IN	O
directed  	directed  	 JJ	O
therapy 	therapy 	 NN	O
,  	,  	 ,	O
voriconazole  	voriconazole  	 NN	B-NP
was  	was  	 VBD	O
superior  	superior  	 JJ	O
to  	to  	 TO	O
amphotericin  	amphotericin  	 VB	O
B  	B  	 NNP	O
for  	for  	 IN	O
overall  	overall  	 JJ	O
survival 	survival 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
both  	both  	 DT	O
voriconazole  	voriconazole  	 NN	B-NP
and  	and  	 CC	O
liposomal  	liposomal  	 JJ	B-NP
amphotericin  	amphotericin  	 JJ	I-NP
B  	B  	 NNP	I-NP
were  	were  	 VBD	O
superior  	superior  	 JJ	O
to  	to  	 TO	O
amphotericin  	amphotericin  	 VB	O
B  	B  	 NNP	O
and  	and  	 CC	O
amphotericin  	amphotericin  	 JJ	B-NP
B  	B  	 NN	I-NP
colloidal  	colloidal  	 NN	I-NP
dispersion  	dispersion  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
outcome  	outcome  	 NN	O
of  	of  	 IN	O
response 	response 	 NN	O
.  	.  	 .	O
While  	While  	 IN	O
limited  	limited  	 JJ	O
to  	to  	 TO	O
some  	some  	 DT	O
degree  	degree  	 NN	O
by  	by  	 IN	O
the  	the  	 DT	O
availability  	availability  	 NN	O
of  	of  	 IN	O
RCTs 	RCTs 	 NNP	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
MTCs  	MTCs  	 NN	B-NP
reported  	reported  	 VBD	O
here  	here  	 RB	O
provide  	provide  	 VB	O
the  	the  	 DT	O
best  	best  	 RBS	O
available  	available  	 JJ	O
evidence  	evidence  	 NN	O
of  	of  	 IN	O
relative  	relative  	 JJ	B-NP
therapeutic  	therapeutic  	 JJ	I-NP
success  	success  	 NN	I-NP
for  	for  	 IN	O
different  	different  	 JJ	O
available  	available  	 JJ	O
treatment  	treatment  	 NN	B-NP
strategies 	strategies 	 NNS	I-NP
.  	.  	 .	O
